Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$3,677 Mln
Revenue (TTM)
$1,183 Mln
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
22.8
P/B Ratio
2.3
Industry P/E
--
EV/EBITDA
13.3
Div. Yield
0 %
Debt to Equity
--
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
49,709,718
CFO
€537.88 Mln
EBITDA
€931.46 Mln
Net Profit
€540.52 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Stevanato Group SpA (STVN)
| -31.3 | -11.0 | -31.3 | -33.8 | -18.9 | -- | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
|---|---|---|---|
|
Stevanato Group SpA (STVN)
| -7.7 | 51.9 | -20.0 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.... It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L. Address: Via Molinella 17, Piombino Dese, PD, Italy, 35017 Read more
Executive Chairman
Mr. Franco Stevanato
CEO & Executive Chairman
Mr. Franco Stevanato
Headquarters
Piombino Dese, PD
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Stevanato Group SpA (STVN) is $13.82 (NYSE) as of 02-Apr-2026 11:42 EDT. Stevanato Group SpA (STVN) has given a return of -18.89% in the last 3 years.
The P/E ratio of Stevanato Group SpA (STVN) is 22.83 times as on 31-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
40.90
|
3.70
|
|
2024
|
50.49
|
4.23
|
|
2023
|
49.75
|
6.40
|
|
2022
|
33.30
|
4.78
|
|
2021
|
44.24
|
7.06
|
The 52-week high and low of Stevanato Group SpA (STVN) are Rs 28.00 and Rs 12.89 as of 02-Apr-2026.
Stevanato Group SpA (STVN) has a market capitalisation of $ 3,677 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Stevanato Group SpA (STVN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.07
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.